Melanoma Therapeutics Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 10
SKU : PH1145
excelpdfpowerpoint
180 pages
Report Summary
Table of Contents
List of Tables & Figures
loading
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Proceed to Buy
Request new version
FAQ’s
What is the Projected CAGR value of the Melanoma Therapeutics Market?
Melanoma Therapeutics Market is expected to grow at a CAGR of 11.43% during the forecast period 2024-2031.
Who are the key players in the Melanoma Therapeutics Market?
Major players are Bristol-Myers Squibb Co., Merck, and Co., Inc., F. Hoffmann-La Roche, Ltd., AB Science S.A., Amgen, Inc., Celgene Corp., Daiichi Sankyo Co., Eisai Co., Ltd., GlaxoSmithKline, plc., and Pfizer, Inc.
Related Reports
pharmaceuticals

Glaucoma Therapeutic Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 05
Starting from

$4350

pharmaceuticals

Xerostomia Therapeutics Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 17
Starting from

$4350

pharmaceuticals

Salivary Gland Cancer Treatment Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 October 04
Starting from

$4350

pharmaceuticals

Eczema Therapeutics Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2024 February 02
Starting from

$4350

pharmaceuticals

Leukemia Therapeutics Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2024 February 05
Starting from

$4350

pharmaceuticals

Influenza Therapeutics Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 12
Starting from

$4350